Share

November 17, 2015; 85 (20) Editorial

Relapse in herpes simplex virus encephalitis

It's not just about the virus

James F. Bale, Renaud Du Pasquier
First published October 21, 2015, DOI: https://doi.org/10.1212/WNL.0000000000002132
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
526

Share

Article Information

vol. 85 no. 20 1730-1731
DOI: 
https://doi.org/10.1212/WNL.0000000000002132
PubMed: 
26491087
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published October 21, 2015.

Article Versions

Copyright & Usage: 
© 2015 American Academy of Neurology

Author Disclosures

    1. James F. Bale Jr., MD and
    2. Renaud Du Pasquier, MD
  1. James F. Bale Jr., MD and
    2. Scientific Advisory Boards:

    1. 1. Federal: NIH, Data Safety Monitoring Board, NIAID. No compensation

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. Pediatric Neurology, Manson Publishers, London, UK. 2012

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. Patient Centered Outcomes Research Institute. CDR-1306-03556. Christopher Landrigan (PI) Bringing I-PASS to the Bedside: A communication bundle to improve patient safety and experience. Goals: Determine the relationship between parent communication and medical errors. Role on Project: Site PI

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Renaud Du Pasquier, MD
    3. Scientific Advisory Boards:

    1. Biogen, Novartis, Genzyme

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. Sanofi, Genzyme

    Editorial Boards:

    1. Editorial boards of European Journal of Neurology, Journal of Neurovirology

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. Swiss National Foundation

    Research Support, Foundations and Societies:

    1. Swiss Society for Multiple Sclerosis, Biaggi Foundation

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Departments of Pediatrics and Neurology (J.F.B.), University of Utah School of Medicine, Salt Lake City; and Centre Hospitalier-Universitaire Vaudois (R.D.P.), Lausanne, Switzerland.
  1. Correspondence to Dr. Bale: james.bale{at}hsc.utah.edu or Dr. Du Pasquier: renaud.du-pasquier{at}chuv.ch
View Full Text

Article usage

Article usage: October 2015 to April 2023

AbstractFullPdfSource
Oct 2015186028Highwire
Nov 201560153116Highwire
Dec 20151521722Highwire
Jan 201669714Highwire
Feb 201662712Highwire
Mar 20165649Highwire
Apr 20166526Highwire
May 20167659Highwire
Jun 20167023Highwire
Jul 20164310Highwire
Aug 20165221Highwire
Sep 20168749Highwire
Oct 20167112Highwire
Nov 20164800Highwire
Dec 20167603Highwire
Jan 20177811Highwire
Feb 201710514Highwire
Mar 20177613Highwire
Apr 20176715Highwire
May 20179231Highwire
Jun 201710802Highwire
Jul 20178074Highwire
Aug 20178526Highwire
Sep 20175004Highwire
Oct 201710104Highwire
Nov 201711113Highwire
Dec 2017102014Highwire
Jan 201811629Highwire
Feb 201886128Highwire
Mar 201896120Highwire
Apr 20187736Highwire
May 2018123222Highwire
Jun 201894010Highwire
Jul 2018119311Highwire
Aug 2018108110Highwire
Sep 20189745Highwire
Oct 201811407Highwire
Nov 201814829Highwire
Dec 201813518Highwire
Jan 201913514Highwire
Feb 201912025Highwire
Mar 201912421Highwire
Apr 201912123Highwire
May 20199047Highwire
Jun 20196621Highwire
Jul 20195721Highwire
Aug 20197832Highwire
Sep 20194210Highwire
Oct 20196111Highwire
Nov 20197111Highwire
Dec 20194630Highwire
Jan 20208933Highwire
Feb 20205035Highwire
Mar 20204000Highwire
Apr 20206722Highwire
May 20205114Highwire
Jun 20205041Highwire
Jul 20203410Highwire
Aug 20203711Highwire
Sep 20206443Highwire
Oct 20203733Highwire
Nov 20204220Highwire
Dec 20205200Highwire
Jan 20215110Highwire
Feb 20217223Highwire
Mar 20216421Highwire
Apr 20215010Highwire
May 20213010Highwire
Jun 20213721Highwire
Jul 20214310Highwire
Aug 20214141Highwire
Sep 20216701Highwire
Oct 20214010Highwire
Nov 20213421Highwire
Dec 20215010Highwire
Jan 20225712Highwire
Feb 20226100Highwire
Mar 20225021Highwire
Apr 20223412Highwire
May 20224131Highwire
Jun 20222311Highwire
Jul 20223312Highwire
Aug 20225846Highwire
Sep 20224545Highwire
Oct 20221715Highwire
Nov 20225141Highwire
Dec 20222546Highwire
Jan 20234022Highwire
Feb 20232631Highwire
Mar 20232852Highwire
Apr 20233363Highwire

Cited By...

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

Topics Discussed

Alert Me

Recommended articles